Literature DB >> 32944135

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5).

Rachel L Palte1, Sebastian E Schneider1, Michael D Altman1, Robert P Hayes2, Shuhei Kawamura1, Brian M Lacey1, My Sam Mansueto1, Michael Reutershan1, Phieng Siliphaivanh1, Christopher Sondey1, Haiyan Xu1, Zangwei Xu1, Yingchun Ye1, Michelle R Machacek1.   

Abstract

Protein arginine methyltransferase 5 (PRMT5) belongs to a family of enzymes that regulate the posttranslational modification of histones and other proteins via methylation of arginine. Methylation of histones is linked to an increase in transcription and regulates a manifold of functions such as signal transduction and transcriptional regulation. PRMT5 has been shown to be upregulated in the tumor environment of several cancer types, and the inhibition of PRMT5 activity was identified as a potential way to reduce tumor growth. Previously, four different modes of PRMT5 inhibition were known-competing (covalently or non-covalently) with the essential cofactor S-adenosyl methionine (SAM), blocking the substrate binding pocket, or blocking both simultaneously. Herein we describe an unprecedented conformation of PRMT5 in which the formation of an allosteric binding pocket abrogates the enzyme's canonical binding site and present the discovery of potent small molecule allosteric PRMT5 inhibitors.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32944135      PMCID: PMC7488283          DOI: 10.1021/acsmedchemlett.9b00525

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

1.  Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.

Authors:  Konstantinos J Mavrakis; E Robert McDonald; Michael R Schlabach; Eric Billy; Gregory R Hoffman; Antoine deWeck; David A Ruddy; Kavitha Venkatesan; Jianjun Yu; Gregg McAllister; Mark Stump; Rosalie deBeaumont; Samuel Ho; Yingzi Yue; Yue Liu; Yan Yan-Neale; Guizhi Yang; Fallon Lin; Hong Yin; Hui Gao; D Randal Kipp; Songping Zhao; Joshua T McNamara; Elizabeth R Sprague; Bing Zheng; Ying Lin; Young Shin Cho; Justin Gu; Kenneth Crawford; David Ciccone; Alberto C Vitari; Albert Lai; Vladimir Capka; Kristen Hurov; Jeffery A Porter; John Tallarico; Craig Mickanin; Emma Lees; Raymond Pagliarini; Nicholas Keen; Tobias Schmelzle; Francesco Hofmann; Frank Stegmeier; William R Sellers
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

2.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.

Authors:  Gregory V Kryukov; Frederick H Wilson; Jason R Ruth; Joshiawa Paulk; Aviad Tsherniak; Sara E Marlow; Francisca Vazquez; Barbara A Weir; Mark E Fitzgerald; Minoru Tanaka; Craig M Bielski; Justin M Scott; Courtney Dennis; Glenn S Cowley; Jesse S Boehm; David E Root; Todd R Golub; Clary B Clish; James E Bradner; William C Hahn; Levi A Garraway
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

3.  Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML.

Authors:  S Kaushik; F Liu; K J Veazey; G Gao; P Das; L F Neves; K Lin; Y Zhong; Y Lu; V Giuliani; M T Bedford; S D Nimer; M A Santos
Journal:  Leukemia       Date:  2017-06-30       Impact factor: 11.528

4.  PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins.

Authors:  T L Branscombe; A Frankel; J H Lee; J R Cook; Z Yang ; S Pestka; S Clarke
Journal:  J Biol Chem       Date:  2001-06-18       Impact factor: 5.157

5.  Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells.

Authors:  Katia Ancelin; Ulrike C Lange; Petra Hajkova; Robert Schneider; Andrew J Bannister; Tony Kouzarides; M Azim Surani
Journal:  Nat Cell Biol       Date:  2006-05-14       Impact factor: 28.824

Review 6.  Versatility of PRMT5-induced methylation in growth control and development.

Authors:  Vrajesh Karkhanis; Yu-Jie Hu; Robert A Baiocchi; Anthony N Imbalzano; Saïd Sif
Journal:  Trends Biochem Sci       Date:  2011-10-03       Impact factor: 13.807

7.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

Review 8.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

9.  Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors.

Authors:  Hong Lin; Min Wang; Yang W Zhang; Shuilong Tong; Raul A Leal; Rupa Shetty; Kris Vaddi; Juan I Luengo
Journal:  ACS Med Chem Lett       Date:  2019-05-22       Impact factor: 4.345

10.  Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.

Authors:  Meng-Chiao Ho; Carola Wilczek; Jeffrey B Bonanno; Li Xing; Janina Seznec; Tsutomu Matsui; Lester G Carter; Takashi Onikubo; P Rajesh Kumar; Man K Chan; Michael Brenowitz; R Holland Cheng; Ulf Reimer; Steven C Almo; David Shechter
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  7 in total

Review 1.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

2.  Novel Chemicals Derived from Tadalafil Exhibit PRMT5 Inhibition and Promising Activities against Breast Cancer.

Authors:  Ziyan Yang; Tian Xiao; Zezhi Li; Jian Zhang; Suning Chen
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

3.  A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.

Authors:  Yudao Shen; Fengling Li; Magdalena M Szewczyk; Levon Halabelian; Irene Chau; Mohammad S Eram; Carlo Dela Seña; Kwang-Su Park; Fanye Meng; He Chen; Hong Zeng; Aiping Dong; Hong Wu; Viacheslav V Trush; David McLeod; Carlos A Zepeda-Velázquez; Robert M Campbell; Mary M Mader; Brian M Watson; Matthieu Schapira; Cheryl H Arrowsmith; Rima Al-Awar; Dalia Barsyte-Lovejoy; H Ümit Kaniskan; Peter J Brown; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2021-02-16       Impact factor: 7.446

4.  Arginine methylation: the promise of a 'silver bullet' for brain tumours?

Authors:  Sabrina F Samuel; Antonia Barry; John Greenman; Pedro Beltran-Alvarez
Journal:  Amino Acids       Date:  2021-01-06       Impact factor: 3.520

5.  The Structural Effects of Phosphorylation of Protein Arginine Methyltransferase 5 on Its Binding to Histone H4.

Authors:  Rita Börzsei; Bayartsetseg Bayarsaikhan; Balázs Zoltán Zsidó; Beáta Lontay; Csaba Hetényi
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

6.  Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy.

Authors:  Yixuan Tang; Shihui Huang; Xingxing Chen; Junzhang Huang; Qianwen Lin; Lei Huang; Shuping Wang; Qihua Zhu; Yungen Xu; Yi Zou
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

7.  Cryo-EM structure-based selection of computed ligand poses enables design of MTA-synergic PRMT5 inhibitors of better potency.

Authors:  Wei Zhou; Gaya P Yadav; Xiaozhi Yang; Feng Qin; Chenglong Li; Qiu-Xing Jiang
Journal:  Commun Biol       Date:  2022-10-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.